while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..anjali shrivastava covers academics and administration. contact her at.my news.